Elevance Health, Inc. (NYSE:ELV) Shares Acquired by HF Advisory Group LLC

HF Advisory Group LLC raised its holdings in shares of Elevance Health, Inc. (NYSE:ELV - Free Report) by 35.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 5,070 shares of the company's stock after purchasing an additional 1,339 shares during the quarter. HF Advisory Group LLC's holdings in Elevance Health were worth $1,870,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also made changes to their positions in the company. Raelipskie Partnership purchased a new stake in shares of Elevance Health in the third quarter valued at approximately $26,000. PSI Advisors LLC bought a new position in shares of Elevance Health during the 3rd quarter worth $27,000. Eastern Bank purchased a new position in shares of Elevance Health during the third quarter valued at $31,000. Dunhill Financial LLC raised its holdings in shares of Elevance Health by 57.8% in the third quarter. Dunhill Financial LLC now owns 71 shares of the company's stock valued at $37,000 after acquiring an additional 26 shares in the last quarter. Finally, Peterson Financial Group Inc. purchased a new stake in Elevance Health in the third quarter worth about $44,000. 89.24% of the stock is owned by hedge funds and other institutional investors.

Elevance Health Stock Performance

ELV traded down $1.00 during trading on Friday, hitting $384.26. 2,696,400 shares of the stock were exchanged, compared to its average volume of 1,457,754. The company has a quick ratio of 1.50, a current ratio of 1.50 and a debt-to-equity ratio of 0.56. Elevance Health, Inc. has a 1-year low of $362.21 and a 1-year high of $567.26. The stock has a fifty day moving average price of $388.02 and a two-hundred day moving average price of $466.63. The firm has a market capitalization of $89.12 billion, a P/E ratio of 14.01, a PEG ratio of 1.08 and a beta of 0.84.

Elevance Health (NYSE:ELV - Get Free Report) last posted its quarterly earnings data on Thursday, October 17th. The company reported $8.37 EPS for the quarter, missing analysts' consensus estimates of $9.66 by ($1.29). Elevance Health had a net margin of 3.68% and a return on equity of 19.56%. The business had revenue of $44.72 billion during the quarter, compared to analyst estimates of $43.47 billion. During the same quarter in the prior year, the firm posted $8.99 earnings per share. The company's revenue for the quarter was up 5.3% compared to the same quarter last year. As a group, sell-side analysts predict that Elevance Health, Inc. will post 32.96 earnings per share for the current year.

Analyst Ratings Changes

Several analysts have issued reports on ELV shares. Mizuho dropped their target price on Elevance Health from $585.00 to $505.00 and set an "outperform" rating on the stock in a research report on Tuesday, November 5th. UBS Group cut their target price on Elevance Health from $605.00 to $555.00 and set a "buy" rating on the stock in a research note on Friday, October 18th. Morgan Stanley decreased their price target on shares of Elevance Health from $643.00 to $551.00 and set an "overweight" rating for the company in a research report on Wednesday, October 23rd. StockNews.com upgraded shares of Elevance Health from a "hold" rating to a "buy" rating in a research note on Friday. Finally, Truist Financial lowered their target price on shares of Elevance Health from $520.00 to $480.00 and set a "buy" rating for the company in a research note on Monday, January 6th. One analyst has rated the stock with a sell rating, two have issued a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $536.53.

About Elevance Health

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.